Impact of gene expression profiling tests on breast cancer outcomes

prepared for Agency for Healthcare Research and Quality, U.S. Dept. of Health and Human Services ; prepared by the Johns Hopkins University Evidence-based Practice Center ; investigators, Luigi Marchionni . [et al.]. ; "Contract No. 290-02-0018." ; "January 2008." ; "The Agency for Healthcare Research and Quality (AHRQ), through its Evidence-Based Practice Centers (EPCs), sponsors the development of evidence reports and technology assessments to assist public- and private-sector organizations in their efforts to improve the quality of health care in the United States. The Centers for Disease Control and Prevention (CDC) requested and provided funding for this report. The reports and assessments provide organizations with comprehensive, science-based information on common, costly medical conditions and new health care technologies. The EPCs systematically review the relevant scientific literature on topics assigned to them by AHRQ and conduct additional analyses when appropriate prior to developing their reports and assessments." - p. iii ; Also available via the World Wide Web. ; Includes bibliographical references (p. 101-105). ; Marchionni L, Wilson RF, Marinopoulos SS, Wolff AC, Parmigiani G, Bass EB, Goodman SN. Impact of Gene Expression Profiling Tests on Breast Cancer Outcomes. Evidence Report/Technology Assessment No. 160. (Prepared by The Johns Hopkins University Evidencebased Practice Center under contract No. 290-02-0018). AHRQ Publication No. 08-E002. Rockville, MD: Agency for Healthcare Research and Quality. January 2008.